Designation: Assistant Professor
Department: Medicine
University: Minia University
Country: Egypt
Dr. Mina T. Kelleni is a 36 years old assistant professor of pharmacology at the faculty of medicine, Minia University, Egypt. He is also a clinician practicing internal, family medicine and dermatology since 2006. He has published more than 28 papers in reputed journals; invited to speak in tens of international medical conferences in cities all over Europe, Asia, Australia, USA and a member of the organizing committee of four international medical conferences. He obtained his MBBS degree with honour in 2004. He’s chosen a career in pharmacology after feeling frustrated from the lack of effective remedies for many diseases dedicating sincere efforts in his MSc research to explore a new remedy for NAFLD and in his Ph.D. research to decrease the toxicity of antineoplastic drugs. He's struggling to raise Pharmacovigilance in Egypt as well as to ban the toxic and carcinogenic drugs which are sorrowfully widely circulating in the Middle East
Diabetes Mellitus, Obesity, Autoimmune disorders, Cancer chemotherapy, NAFLD, HCV Pharmacotherapy, and Pharmacovigilance
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.
